Popular Keywords
Allergy
Cosmetic Dermatology
Cryosurgery
Dermatopathology
Hair Transplantation
Immunodermatology
Correspondence to Author: Kazar Jadi Baluki1,
Laser Research Unit, College of Medicine, University of Kufa, Iraq.
Abstract:
Background: chloasma may be a common skin disorder associate degreed optical device began to be an possibility of treatment. Objective: to check between the effectiveness of Erbium: Glass 1540 nm optical device and Nd: YAG Q-Switched 1064nm optical device within the treatment of chloasma. Methods: This comparative split face clinical study was meted out in optical device analysis Unit, school of medication, University of Kufa, Iraq; for the amount from October 2012 to December 2013. every patient’s face was divided into 2 halves, every [*fr1] was treated with one among the 2 optical device devices employed in this study; third Erbium: Glass 1540nm and Nd: YAG Q-Switched 1064nm lasers. The severity of chloasma was assessed before, once treatment and three months later with the changed chloasma space and Severity Index (MASI) Score and by images. Results: The mean changed MASI scores were reduced within the facial halves treated by Erbium: Glass 1540nm optical device (statistically extremely important P worth of zero.001) quite those treated by Nd: YAG Q-Switched 1064nm optical device (statistically important P worth of zero.022). Conclusion: The treatment was well tolerated and patients incontestable positive responses with promising results.
Keywords:
Melasma, Erbium, Glass laser, Nd, YAG Q-Switched laser.
Citation:
Kazar Jadi Baluki1. A Split Face Comparative Study of Melasma Treatment with Fractional Erbium: Glass 1540 Nanometer and Nd: YAG Q-Switched 1064 Nanometer Laser Systems. Annals of Dermatological Science 2024.
Journal Info
- Journal Name: Annals of Dermatological Science
- Impact Factor: 1.7
- ISSN: 2831-8129
- DOI: 10.52338/Aods
- Short Name: AODS
- Acceptance rate: 55%
- Volume: 6 (2024)
- Submission to acceptance: 25 days
- Acceptance to publication: 10 days
OUR PUBLICATION BENEFITS
- International Reach
- Peer Review
- Rapid Publication
- Open Access
- High Visibility